Maxmarvil

Asset

Combination of alendronate and calcitriol inhibiting bone resorption and regulating calcium homeostasis

Stage: Phase 1
Modality: Small molecule
Target: VDR; 1
Indication: 75
Trials: 1
Developer

Indications

1

Osteoporosis
Phase 1, Completed, NCT01526278, clinicaltrials.gov, 7 Oct 2026

In the full profile

Targets and what it contains3
Owner and partners1
Trials75
Evidence for its targets3
Competitors7

Every asset’s record: target, stage, trials and the evidence behind it.